Recommendations on the Clinical Management of the COVID-19 Infection by the «new Coronavirus» SARS-CoV2. Spanish Paediatric Association Working Group

Overview

Journal An Pediatr (Engl Ed)

Publisher Elsevier

Specialty Pediatrics

Date 2020 Apr 29

PMID 32341943

Citations 18

Authors

Cristina Calvo

Milagros Garcia Lopez-Hortelano

Juan Carlos De Carlos Vicente

Jose Luis Vazquez Martinez

Affiliations

Soon will be listed here.

Abstract

On 31 December 2019, the Wuhan Municipal Committee of Health and Healthcare (Hubei Province, China) reported that there were 27 cases of pneumonia of unknown origin with symptoms starting on the 8 December. There were 7 serious cases with common exposure in market with shellfish, fish, and live animals, in the city of Wuhan. On 7 January 2020, the Chinese authorities identified that the agent causing the outbreak was a new type of virus of the family, temporarily called «new coronavirus», 2019-nCoV. On January 30th, 2020, the World Health Organisation (WHO) declared the outbreak an International Emergency. On 11 February 2020 the WHO assigned it the name of SARS-CoV2 and COVID-19 (SARS-CoV2 and COVID-19). The Ministry of Health summoned the Specialties Societies to prepare a clinical protocol for the management of COVID-19. The Spanish Paediatric Association appointed a Working Group of the Societies of Paediatric Infectious Diseases and Paediatric Intensive Care to prepare the present recommendations with the evidence available at the time of preparing them.

Citing Articles

Genetic, Structural, Physicochemical, and Molecular Epidemiological Landscape of Three New Mutations Found in the Spike (S) Protein of Highly Transmissible Sri Lankan Delta Variant Sub-lineage AY.28: A222V, A701S, and A1078S.

Gunawardana D J Environ Public Health. 2024; 2022:4364131.

PMID: 39297175 PMC: 11410427. DOI: 10.1155/2022/4364131.

Management of SARS-CoV-2 Prevention Methods in Dental Offices-A Cross-Sectional Study in Bucharest, Romania.

Nicolescu M, Lupu O, Georgescu R, Sandulescu M, Funieru C Healthcare (Basel). 2024; 12(12).

PMID: 38921284 PMC: 11203912. DOI: 10.3390/healthcare12121169.

COVID-19 CT-images diagnosis and severity assessment using machine learning algorithm.

Albataineh Z, Aldrweesh F, Alzubaidi M Cluster Comput. 2023; :1-16.

PMID: 36712413 PMC: 9871425. DOI: 10.1007/s10586-023-03972-5.

Guidelines for the prevention and management of children and adolescents with COVID-19.

Liu E, Smyth R, Li Q, Qaseem A, Florez I, Mathew J Eur J Pediatr. 2022; 181(12):4019-4037.

PMID: 36109390 PMC: 9483317. DOI: 10.1007/s00431-022-04615-4.

Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection.

Pua Torrejon R, Ordono Saiz M, Gonzalez Alguacil E, Furones Garcia M, Cantarin Extremera V, Ruiz Falco M Pediatr Neurol. 2022; 136:28-33.

PMID: 36084419 PMC: 9343071. DOI: 10.1016/j.pediatrneurol.2022.07.006.

References

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Lu H . Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020; 14(1):69-71. DOI: 10.5582/bst.2020.01020. View

Holshue M, DeBolt C, Lindquist S, Lofy K, Wiesman J, Bruce H . First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382(10):929-936. PMC: 7092802. DOI: 10.1056/NEJMoa2001191. View

Weiss S, Peters M, Alhazzani W, Agus M, Flori H, Inwald D . Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020; 21(2):e52-e106. DOI: 10.1097/PCC.0000000000002198. View

Agostini M, Andres E, Sims A, Graham R, Sheahan T, Lu X . Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. mBio. 2018; 9(2). PMC: 5844999. DOI: 10.1128/mBio.00221-18. View

Sheahan T, Sims A, Leist S, Schafer A, Won J, Brown A . Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020; 11(1):222. PMC: 6954302. DOI: 10.1038/s41467-019-13940-6. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer R . Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017; 43(3):304-377. DOI: 10.1007/s00134-017-4683-6. View

10.

Jean A, Quach C, Yung A, Semret M . Severity and outcome associated with human coronavirus OC43 infections among children. Pediatr Infect Dis J. 2013; 32(4):325-9. DOI: 10.1097/INF.0b013e3182812787. View

11.

Davis A, Carcillo J, Aneja R, Deymann A, Lin J, Nguyen T . American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med. 2017; 45(6):1061-1093. DOI: 10.1097/CCM.0000000000002425. View

12.

Shen K, Yang Y, Wang T, Zhao D, Jiang Y, Jin R . Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts' consensus statement. World J Pediatr. 2020; 16(3):223-231. PMC: 7090771. DOI: 10.1007/s12519-020-00343-7. View

13.

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

14.

Khemani R, Smith L, Zimmerman J, Erickson S . Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference. Pediatr Crit Care Med. 2015; 16(5 Suppl 1):S23-40. DOI: 10.1097/PCC.0000000000000432. View

15.

Lee J, Storch G . Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children <5 years of age. Pediatr Infect Dis J. 2014; 33(8):814-20. DOI: 10.1097/INF.0000000000000292. View

16.

Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M . Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3):269-271. PMC: 7054408. DOI: 10.1038/s41422-020-0282-0. View

17.

Delaney J, Pinto R, Long J, Lamontagne F, Adhikari N, Kumar A . The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Crit Care. 2016; 20:75. PMC: 4818504. DOI: 10.1186/s13054-016-1230-8. View

18.

Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A . Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020; 395(10223):e30-e31. PMC: 7137985. DOI: 10.1016/S0140-6736(20)30304-4. View

19.

Cai J, Wang X, Ge Y, Xia A, Chang H, Tian H . [First case of 2019 novel coronavirus infection in children in Shanghai]. Zhonghua Er Ke Za Zhi. 2020; 58(0):E002. DOI: 10.3760/cma.j.issn.0578-1310.2020.0002. View

20.

Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K . Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004; 59(3):252-6. PMC: 1746980. DOI: 10.1136/thorax.2003.012658. View